Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $171.1M
Liabilities Breakdown FY2021
Total Liabilities: $82.8M
Asset Breakdown
Total Assets: $171.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $112.6M | 65.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.0M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $57.5M | 33.6% |
Liabilities Breakdown
Total Liabilities: $82.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 1.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $81.7M | 98.7% |